131 related articles for article (PubMed ID: 38214381)
21. Technical note: Dosimetry and FLASH potential of UHDR proton PBS for small lung tumors: Bragg-peak-based delivery versus transmission beam and IMPT.
van Marlen P; van de Water S; Slotman BJ; Dahele M; Verbakel W
Med Phys; 2024 May; ():. PubMed ID: 38795376
[TBL] [Abstract][Full Text] [Related]
22. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.
Welsh J; Gomez D; Palmer MB; Riley BA; Mayankkumar AV; Komaki R; Dong L; Zhu XR; Likhacheva A; Liao Z; Hofstetter WL; Ajani JA; Cox JD
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1336-42. PubMed ID: 21470796
[TBL] [Abstract][Full Text] [Related]
23. Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams.
van Marlen P; Dahele M; Folkerts M; Abel E; Slotman BJ; Verbakel WFAR
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):621-629. PubMed ID: 31759074
[TBL] [Abstract][Full Text] [Related]
24. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation : A PLANNING COMPARISON OF DEEP INSPIRATION BREATH HOLD INTENSITY MODULATION RADIOTHERAPY AND INTENSITY MODULATED PROTON THERAPY.
Baues C; Marnitz S; Engert A; Baus W; Jablonska K; Fogliata A; Vásquez-Torres A; Scorsetti M; Cozzi L
Radiat Oncol; 2018 Jul; 13(1):122. PubMed ID: 29970105
[TBL] [Abstract][Full Text] [Related]
25. Dose and dose rate objectives in Bragg peak and shoot-through beam orientation optimization for FLASH proton therapy.
Ramesh P; Gu W; Ruan D; Sheng K
Med Phys; 2022 Dec; 49(12):7826-7837. PubMed ID: 36222217
[TBL] [Abstract][Full Text] [Related]
26. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
[TBL] [Abstract][Full Text] [Related]
27. A single-field integrated boost treatment planning technique for spot scanning proton therapy.
Zhu XR; Poenisch F; Li H; Zhang X; Sahoo N; Wu RY; Li X; Lee AK; Chang EL; Choi S; Pugh T; Frank SJ; Gillin MT; Mahajan A; Grosshans DR
Radiat Oncol; 2014 Sep; 9():202. PubMed ID: 25212571
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
29. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
30. Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
Stuschke M; Kaiser A; Abu Jawad J; Pöttgen C; Levegrün S; Farr J
Radiat Oncol; 2013 Jun; 8():145. PubMed ID: 23773560
[TBL] [Abstract][Full Text] [Related]
31. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.
Ding X; Li X; Zhang JM; Kabolizadeh P; Stevens C; Yan D
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1107-1116. PubMed ID: 27869083
[TBL] [Abstract][Full Text] [Related]
32. Impact of different treatment techniques for pediatric Ewing sarcoma of the chest wall: IMRT, 3DCPT, and IMPT with/without beam aperture.
Su Z; Indelicato DJ; Mailhot RB; Bradley JA
J Appl Clin Med Phys; 2020 Jun; 21(6):100-107. PubMed ID: 32268008
[TBL] [Abstract][Full Text] [Related]
33. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous dose and dose rate optimization (SDDRO) for FLASH proton therapy.
Gao H; Lin B; Lin Y; Fu S; Langen K; Liu T; Bradley J
Med Phys; 2020 Dec; 47(12):6388-6395. PubMed ID: 33068294
[TBL] [Abstract][Full Text] [Related]
35. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
[TBL] [Abstract][Full Text] [Related]
36. Mixed integer programming with dose-volume constraints in intensity-modulated proton therapy.
Zhang P; Fan N; Shan J; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2017 Sep; 18(5):29-35. PubMed ID: 28681976
[TBL] [Abstract][Full Text] [Related]
37. Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.
Jensen MF; Hoffmann L; Petersen JBB; Møller DS; Alber M
Med Phys; 2018 Oct; 45(10):4355-4363. PubMed ID: 30129041
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
39. Helical tomotherapy and intensity modulated proton therapy in the treatment of dominant intraprostatic lesion: a treament planning comparison.
Fellin F; Azzeroni R; Maggio A; Lorentini S; Cozzarini C; Di Muzio N; Fiorino C; Calandrino R; Schwarz M
Radiother Oncol; 2013 May; 107(2):207-12. PubMed ID: 23541644
[TBL] [Abstract][Full Text] [Related]
40. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]